JOURNALOF BONE ANDMINERAL RESEARCH
Volume 11,Number12,1996
Blackwell Science, Inc.
© 1996American Societyfor Boneand MineralResearch
Correcting Calcium Nutritional Deficiency Prevents Spine
Fractures in Elderly Women*
ROBERT R. RECKER, SHARILYN HINDERS, K. MICHAELDAVIES, ROBERT P. HEANEY,
MARY RUTH STEGMAN, JOAN M. LAPPE, and DONALD B. KIMMEL
ABSTRACT
Wetested the spine antifractureandbone sparingefficacyof1.2Wdayoforal calcium as carbonatein twogroups
= =
ofelderlywomen,onewith prevalentfractures (PF,n 94)onentryandthe otherwithout (NPF,n 100).Itwas
a prospective randomized,double-blind, placebo-controUedtrialin mostly rural communitiesin womenoverage
60who were living independently and were consuming <1 Wdayof calcium. We obtained annual lateral spine
radiographs and semiannual forearm bone density over 4.3 ± 1.1years and determined vertebral fractures by
radiographicmorphometryaugmentedbyphysician assessment.In the PFgroup, 15of53subjects oncalcium had
= K).
incidentfractures, comparedwith21of41onplacebo (p 0.023, Calcium did not reduce the rateofincident
fractures in the NPF group. Thosewith a prevalentfracture onentryand not treatedwith calciumwere2.8times
more likelytoexperience anincidentfracture thanallothers.Changein the forearmbone mass on placeboin the
PFgroupwas -1.24 ± 2.41%/yearcomparedwith +0.31 ± 1.8O%/yearoncalcium (p < 0.001).Inthe NPFgroup,
the difference was less: -0.39 ± 2.08%/yearversus 0.00 ± 1.64%/year(p = 0.2). We conclude that in elderly
postmenopausalwomenwith spine fractures and selfselectedcalcium intakesof <1g/day, a calcium supplement
of 1.2Wdayreduces the incidence of spine fractures and halts measurable bone loss. (J Bone MinerRes 1996;
11:1961-1966)
INTRODUCTION ingspinefractures,whohadlowself-chosencalciumintakes
andwere fullyambulatory and livingindependently.
C ALCIUM INTAKE is an important determinant of bone
health. All postmenopausal calcium intervention
(1-8)
studies reported since 1988inwhichthe investigatorcon MATERIALS AND METHODS
trolled the calcium intake of a test group and excluded
Subjects
womenwithin5yearsof menopause havedemonstrated a
bone sparingeffectbyserialmeasurementofbone mass.v? The subjects were healthy white women volunteers of
Nevertheless,self-chosencalciumintakes remain generally Europeanancestry,aged73.5± 7.1years,whowereambu
below recommended levels'?' for women of all ages, and latoryandlivingindependently.Thestudywasapprovedby
physiciansseem to regard increasing calcium intake as a the Creighton University Institutional Review Board. All
minor modality in the management of the bone health of subjectsgaveinformedconsent. RecruitmentbeganinNo
elderlywomen. vember 1987,and ended in January 1990.Fifty-five study
We report here the spine antifracture and bone-sparing sites,mostofwhichweregovernment-sponsored mealsites
efficacyresultsof acalciumintervention trial between two established for the elderly,were used. About 75% of the
groupsofelderlywomen,thosewithandwithoutpre-exist- subjects lived in rural communities, and 25% lived in
Omaha.Enrollmentwaslimitedtohealthypostmenopausal
womenoverage60whoseusualcalciumintakeswere esti
*Presentedas an abstract, J Bone MinerRes 9:S154,1995. mated to be <1 g/day.There wasno upper agelimit.
OsteoporosisResearch Center,The Departmentof Medicine,CreightonUniversity, School of Medicine,Omaha, Nebraska, U.S.A.
1961
1962 RECKER ET AL.
We designed the study to evaluate spine fracture inci tebral deformity or fracture wasdefined morphometrically
dence and forearm bone masschanges intwogroups; those asvertebral heights >2.5 and >4standarddeviations (SD)
with prevalentspine fractures (PF) and those withoutprev below the reference population mean, for wedge and com
alent fractures (NPF) on entry. Subjects with other diag pression deformities, respectively. A vertebra was called
noses orwith treatments known to affect the skeletonwere deformed if either or both of these criteria were met.
excluded. However, therewasawidevarietyofmildchronic These values are the empirically determined thresholds
illness in members of the study population, precisely the of detection of vertebral deformity by an experienced
universe of people affected most by osteoporosis. Of 750 clinician.(11-13)
candidatesscreenedforentry, 251were entered.Abouthalf Qualitative classification, prevalent fractures: After com
of the 499 who were screened but not enrolled were re pletion of the morphometric measurements, the films of
jectedbecausecalcium intake levelswereabove 1g/day(see each individual were reviewed as a group by a clinician
below). The otherhalfchose not to enrollwhen the details (RR.R.), and all vertebrae were scrutinized. Positive and
ofthe protocolwere explained. Nobaseline bone densityor negative calls of prevalent fracture by the algorithm were
spine fracture data were obtained from the 499 who were judged against the clinician's assessment, which was taken
not enrolled.Ofthe 251subjectswhowereentered,54were as the standard.
excluded from analysisbecause they underwent lessthan 1 Quantitative classification, incident fractures: Incident de
year of observation. Forty-seven withdrew after screening formities of vertebrae were defined morphometrically as
before any serial data were obtained, and seven remained >20% reduction in anterior or posterior height relative to
on the study for less than a year. They yielded few serial earliermeasured values.(14,15)
bone density data and no fracture data. Because of the
Qualitative classification, incident fractures: During the
small amount of treatment data and the short term of
review of the entire set of films of each subject, after
treatment, all54were simplyconsidered to be inthe same
completion of the morphometric measurements, the clini
category as those who declined to participate after screen
cian (RR.R) also scrutinized all vertebrae for incident
ing. Of the 197who were entered into the analysis, there
fractures. Positiveand negative callsofincidentfracturesby
were 12deaths after 1-3.5 years of observation and 6who
the algorithm were judged against the clinician's assess
moved out of the area after 1-4.5 years of observation.
ment, which was again taken as the standard.
Allthe morphometricand clinician evaluationswere per
Protocol formed before the blind wasbroken. The final decision on
all prevalent and incident fractures was made by the clini
Thiswasaprospective, randomized,double-blind, place
cian during visualizationofthe films,with the morphomet
bo-controlled trial. As predicted from previous data, (L.J.
ricresults available at the time ofthe evaluation. Since the
Melton, personal communicationj-'?' the PF and NPF
quantitative algorithmsseemedto overdiagnoseboth prev
groups were of nearly equal size, at n = 94 and 103,
alent and incidentvertebral deformity, the more conserva
respectively. For logistical reasons, it was not practical to
tive results obtained by the clinician's reading of the films
randomizetreatmentaccordingtoprevalentfracturestatus.
were used in the analysis. This approach, combining mor
The subjects were thus randomizedwithoutregard to prev
phometrywith confirmation by a trained expert, has been
alent fracture status to receive either calcium carbonate
recommended by an expert panel(l4,15) as an acceptable
tablets(Caltrate,LederleLaboratories,Wayne NJ, U.S.A.)
method of eliminating false positives and false negatives
or identicalappearingplacebo,twicedailywitheach oftwo
produced by radiographic morphometry.
meals. The calcium tablets each contained 600 mg of cal
cium. The treatment code was not broken until all the
experimental data were obtained.
Each studysitewasvisitedat intervals of6months. Visits SingLephoton absorptiometry
were made with a customized van equippedwith an X-ray
Bone masswas measured by125I_based SPA, expressing
unit, film processor, and a single photon absorptiometer
(SPA) (Model 2780,Norland Corporation, Fort Atkinson, bone mineral content (BMC, g) measured at a site on the
WI, U.S.A.). At each visit, interim history was obtained, radius one-third the distance from the styloid to the olec
pillswere dispensed, and bone density was measured. Lat ranon. Precision was 2.0%. Since we were interested in
eral spine radiographswere obtained at intervals of 1year. within-person changes and had no need to minimize inter
Compliance was expressed as the percentage of pills pre individual variation,and since BMC isamore precise mea
scribed that were not returned on a subsequent visit. Lat sure than BMC/BW with this instrument, we report here
eral thoracic and lumbar spine films were taken in the only BMC
upright position inside the mobile unit understandardized Avalue for the annual rate ofbone lossfor each subject
conditionswith a tube-to-film distance of 40in. was derived from densitometry measurements as follows.
The completesetofvalues from each subject wasaveraged,
and each individual measurement was expressed as a frac
VertebraL morphometry
tion of the subject'smean, A slope wascalculatedfor each
Quantitative classification, prevalent fractures: Vertebral subject with the resulting normalized BMC as the depen
morphometry was performed on each film according to dent variable and the time of observation as the indepen
methods previously described in our laboratory.(1l·12) Ver- dent variable, Changewas then expressed as a rate.
ANTIFRACTURE EFFICACY OF CALCIUM 1963
TABLE 1. BASELINE COMPARISON
Prevalentfracturegroup Nonprevalentfracture group
Calcium Placebo Calcium Placebo
(n = 51) (n = 41) (n = 40) (n = 59)
mean SD mean SD mean SD mean SD
Age 75.4 7.3 74.2 6.9 72.8 6.1 72.1 7.5
BMC (g)* 0.706 0.118 0.694 0.126 0.724 0.151 0.783 0.150
Calcium intake 451 179 447 196 386 218 442 184
(mg/day)
•Sixsubjectsdid not havebaseline BMCmeasurements, thus differingfromn for fractures (see
Table3).SD,standarddeviation.
Dietarycalcium intake which the incidentfracturewasvisualizedandtheprevious
visit. Hazard ratios were calculated from the beta coeffi
An estimate of calcium intake from food, medication,
cients derived from the Cox proportional hazards regres
and supplementswas made for each person prior to entry
sion modelandwerecalculatedforeachstandarddeviation
byan abbreviated questionnaire-'? administered bythe re
decrement of the variable.v"? These analyses were com
search nurse in charge of the project (S.H.). Candidates
putedusing theStatisticalAnalysisSystem (SAS,Cary,NC,
wereinvitedtovolunteerfor the studyonlyifcalciumintake
U.S.A.) procedures LIFETEST and PHREG.(18) Differ
was estimated to be <1 g/day. Whenever therewas uncer
ences in the rates of change in bone mass between treated
tainty about the validity of a given response, volunteers
and untreated subjects in the PF and NPF groups were
wereinstructedto keepadiary ofallfood and liquid intake
compared byt-tests of means.
over a 7-day period. The completed diaries and question
naireswere analyzedbya dietitianusing Nutripractorsoft
ware (Practorcare, San Diego, CA, U.S.A.). RESULTS
Baseline characteristicsofstudy population
Serum 25hydroxyvitamin D
Table1presentsasummaryofseveralpertinentvariables
Bloodspecimenswereobtainedfrom a randomlychosen at entryinto thestudy.Thefour subgroups, (1) prevalent
subset of 38 members of the cohort at the beginning of fracture-calcium (PF-calcium), (2) prevalent fracture
observation, at the endof 2years, and again at the end of placebo (PF-placebo), (3) nonprevalentfracture-calcium
the study. The serum 25 hydroxyvitamin D (250HD) con (NPF-ca1cium), and (4) nonprevalent fracture-placebo
centrationwas measuredbyacompetitivebindingassaykit (NPF-placebo),weresimilarin age andcustomarycalcium
(Nichols Institute Diagnostics, San Juan Capistrano, CA, intake.Ofthe 94PFsubjects,53hadoneprevalentfracture,
U.S.A.). The sensitivity of this assay is2.2ng/mI. 26 had two, 11 had three, and 4 had more than three. As
expected.i'?'the baseline BMC was significantly greaterin
Statistics the NPFgroupthaninthe PFgroup(0.760 ± 0.152,n = 99,
vs. 0.701 ± 0.120, n = 92; P < 0.(02). Serum 250HD,
The study was designed in advance to permit indepen measuredon a subsetof 38 individuals,was 62.5 ± 15and
dent analysis of the PF and NPF groups. We analyzed 65.0 ± 22.5 nmol/ml, respectively, in the calcium and pla
incident fracture and bone density changes in the PF and cebo-treated subjects (NS).
NPF groups by "intention-to-treat." The difference in the
numbersof subjectswith incidentvertebraldeformitiesbe
Incidence ofspinefracture
tween treated and untreated subjects in the PF and NPF
groupswas testedbythe Chi squarewith Yates'correction. Duringthe 4.3 ± 1.1years of observation, 36personsin
Then, to examine the relative contributions of the vari the PF group (n = 94) had 86 incidentvertebral deformi
ables (prevalent deformity, initial bone mass, and treat ties. Sixty-twoinvolved previouslynormalvertebrae,and24
ment) to vertebral fracture incidence, we used the Cox involved 18 previously deformed vertebrae. In the NPF
proportional hazards regression model for both univariate group (n = 103), 25 persons had 59 incident vertebral
and multivariate survival analysis in the entire cohort. deformities. Fifty-two involved previously normal verte
Model determinationwas made according to the methods brae,and seven involvedsixpreviouslydeformedvertebrae.
describedbyKleinbaum,Kupper,andMorgenstern.P'"The Thenumberof personswith andwithoutincidentfractures
assumptionsfor theuseofthissurvivalanalysisweremet,as ineachofthefoursubgroupsisshown inTable2.In thePF
determinedbythe Kaplan-Meiermethodof comparisonof group, calcium supplementation significantly reduced the
survival curves. Each vertebral fracture was estimated to rate of incident fractures (p = 0.023). In the NPF group,
have occurred half way between the date of the visit at calciumsupplementationdid not affect the rate of incident
1964 RECKER ET AL.
TABLE2. EFFECTOF CALCIUM SUPPLEMENTON INCIDENT FRACTURES'
PrevalentFracture Group NonprevalentFracture Group
(P = O.023)t (P = 0.435)
Fracture Status Calcium Placebo" Total Calcium Placebo Total
Incident fractures 15 21 36 12 13 25
No incident fractures 38 20 58 30 48 78
Totals 53 41 94 42 61 103
*The number ineach cellrepresents the number ofsubjects.
t Prevalent calciumvs.prevalent placebo (~).
*
p = 0.002(~), prevalent fracture-placebovs.nonprevalentfracture-placebo.
TABLE 3. ESTIMATED HAzARD RATIOS OF INCIDENT
PF NPF
VERTEBRAL FRACTURES
.. 2
95% ~ P<0.001 P<0.2
->.-
Hazard confidence --
~
Variable ratio intervals 0
CD
Univariate analysis
Ccl
0
eel
Prevalent fracture 1.9 1.14-3.18 s:
0
Initial BMC' 1.43 1.10-1.87
0 -1
Treatment effect 1.23 0.74-2.04 ~
co
Multivariate analysist
Nontreatment X prevalent 2.8 1.64-4.76 -2
fracture (unadjusted) _ Calcium CJI] Placebo
Nontreatment Xprevalent 2.45 1.42-4.20
fracture (adjusted for FIG. 1. Treatment effects on rates of change (mean :!::
initial BMC) SEM, %/year) in forearm bone mass. The treatment effect
was significant in the PF group (0.31 :!:: 0.25 vs. -1.24 :!::
*Hazard ratio foreach standarddeviation decrementofBMC. 0.38,P < 0.001) but not in the NPFgroup (0.00 :!:: 0.26vs.
t First-orderinteractionmodelincluded thevariables:nontreat -0.39 ::':: 0.27,P < 0.2). Among placebo-treated subjects,
ment, prevalentfracture, and treatment x prevalent fracture. the rateofbonelosswasgreaterinthe PFgroupthaninthe
NPFgroup (-1.24 :!:: 0.38vs.-0.39 :!:: 0.27,p = 0.03). The
rate of bone loss in the PF-placebo group was different
from zero (p < 0.01),while that in the NPF-placebogroup
fractures (p = 0.435). Incident fracture was greater in the was marginally significant (p < 0.1).
PF-placebo group than in the NPF-placebogroup (51% in
PF vs.21% in NPF;P = 0.002,,1).
minoramountof the riskof incidentfracture, reducing the
Contribution ofprevalentfracture status, initialBMC,
hazard ratio from 2.8to 2.45.
and calcium supplementation to incidentfracture
(Coxproportional hazards model)
Table 3 shows the univariate and multivariate Cox pro
Change in forearm bone mass
portionalhazardsregressionanalyses.Threecomponentsto
the riskofincidentvertebralfracturewere tested:prevalent Figure 1 presents the data for change in forearm bone
fracture, initial BMC, and treatment effect. Subjects with mass.Twosubjectsinthe PF groupand four subjectsinthe
prevalentfracturewere 1.9times more likelyto experience NPF group did not have initial BMC measurements be
incident fracture than those without prevalent fracture cause of technical problems and are not included either
(95% confidence interval [CI], 1.14-3.18). For each stan hereorinTables1and 3.ThePF-placebogroupwaslosing
dard deviation decrement of initial BMC, the risk of inci bone at a substantially greater rate than the NPF-placebo
dent fracture was increased by 1.43 (95% CI, 1.10-1.87). group (-1.24 :!:: 0.38 vs. -0.39 :!:: 0.27;P = 0.03). In both
Though treatment itself was not associated with incident groups, calcium supplementation completely abolished
vertebralfracture, the first-order interactionmodelshowed loss. The difference was highly significant for the PF
a strong interaction of treatment and prevalent fracture. group(p < 0.001), andnotsignificantfor theNPFgroup
Subjectsinthe PF-placebogroupwere 2.8times morelikely (p < 0.2), likely because the untreated loss rate was
to experience incident fracture than all others (95% CI, much less and the treatment-induced difference corre
1.64-4.76). Adjustment for initial BMC accounted for a spondingly smaller.
ANTIFRACTURE EFFICACY OF CALCIUM 1965
Compliance and side effects to supplementsto the extent that it ispossible or practical
to achieve recommended intakes of 1500mg/day.
Median compliance was 64%, but the distribution was
These data provide the clinician with evidence that the
bimodal,with5% ofeachgroup refusingtoacceptpillsafter
presence of pre-existing spine fractures is a marker that
they had agreed to the study and been entered into the
identifies olderpatientswhowillbenefitmost byincreased
randomization. For the intention-to-treat analysis, they
calcium intake. In such patients, calcium supplementation
were retained in their respective groups.
producesboth adecline inincidence ofvertebraldeformity
Side effects were minor, although eight subjects com
and a slower rate of bone loss. Elderly women without
plained of constipation, seven in the treatment group and
vertebral deformity also benefit by experiencing a mild
one in the placebo group. In none of the subjects did the
slowingin the rate ofbone loss.Thus, one should not wait
constipation result in dropping out of the study, and in all
until fracture occurs in an elderly woman to begin calcium
casesthe constipationwasmanagedbydiet or stool soften
prophylaxis,because anincrease incalciumintake toalevel
ers. No instances of urolithiasis occurred.
at or above the NIH recommendations benefits all.
The failure to observe antifractureefficacyofcalcium in
the NPFgroupwasprobablyrelatedbothtotheirlowerrate
DISCUSSION ofincident fractures, significantlylessthan inthe PF group
(p = 0.023), and to the concentration of the calcium
Our study showed that supplemental calcium in a group dependentsubjectsinthe PF group (see above). Given the
of elderly women with low self-selected calcium intakes number of subjects in the NPF group, in order to have
reduces the risk of incident spine fractures in those who observed a significantcalciumeffect on fracture incidence,
already have them and halts measurable bone loss for at a77%reduction inthe numberofindividualswith incident
least 4 years. This effect was evident despite a median fractures would have been required. No existingtreatment
compliance rate of only64%. for osteoporosis produces such a marked antifracture ef
The majority of U.S. women of all ages have calcium fect. Thus, the data from our NPF group are useful in
intakes that are belowthe 1989RDA(20) and farbelowthe planningantifractureefficacystudies. Theydemonstrate in
recent recommendations of the Optimal Calcium Intake a real world setting the impact on the statistical power to
Consensus Conference.(21) Weenrolledonlywomenwhose detect treatment effects inNPF individualscomparedwith
self-selected calcium intakes were <1 g/day;mean intakes PFindividualsbecause oftheirlowerincidenceoffractures.
atbaseline for allfourofour subgroupswere <500mg/day. Sinceabout two-thirdsofelderlywomen are representedby
This selection criterion was intended to enrich all four the NPF group,(IO) we suggest that a properly powered
subgroups with persons having nutritional calcium defi study of the effect of calcium supplementation on incident
ciency,thus offering a betterchance to demonstrate a cal vertebral deformity in elderly women without prevalent
cium effect. The data of this studythus add to the bodyof fractures isneeded.
evidence demonstrating that suboptimal calcium nutrition Atentry,vertebralfractures were already presentin48%
contributes to the increasing vertebral fracture burden of of our subjects. This value isonly slightlyhigher than the
agingwomen.(8,22,23) smoothedprevalencevalue(38%) among OlmsteadCounty
We observed antifracture efficacyof calcium onlyinthe women over age60.(10) Ourpopulationwasolderthan the
PF group. The likely reason is that the PF group itself OlmsteadCounty group, 68% beingover age 70.The prev
concentrated individuals with nutritional calcium defi alence ofvertebral fracture inwomen over age 70in Olm
ciency. This is suggested by the greater rate of loss of stead County was42%. Furthermore, unlike the Olmstead
forearmBMCand thegreatereffectofcalciumsupplemen County study, our subjects were chosen for low calcium
tationonBMClossinthisgroup. Also,initial bone massin intake, somethingthat ispotentiallyassociated with higher
the PF group was less than that in the NPF group. The prevalent vertebral fracture. Thus, making allowance for
positive response to calcium supplementation observed in somewhat different age distributions and our restrictive
this study, as in most studies of calcium supplementation, calcium intake selection criteria, our fracture prevalence
willtend tobe dominatedbythose membersofatreatment value was compatible with existing data from Olmstead
group who have nutritionalcalciumdeficiency.There isno county.(10)
test forsuchdeficiencybeyond aresponsetocalcium.Con The presenceofvertebralfractures isapowerful marker
centration of such individuals in the PF group istherefore for increased risk of incident vertebral fracture.(29) Our
not surprising. Our subjects were already at the age when datashowthat prevalentfracture issuchapowerfulmarker
fractures typicallyoccur. Those with two risk factors (age predisposing to incident fracture (Cox Hazard ratio 1.9)
related loss and calcium deficiency) would be expected to that its presence might overwhelm a treatment effect. We
exhibit more fractures than those who have onlyone. suggest that osteoporosis treatment trials involvingelderly
While we used calcium carbonate, we believe that the women take into account their prevalent fracture status at
results ofthisstudycanbegeneralizedtonearlyanyformof study onset.
calcium,includingfood calcium,sincenearlyallare equally The bone sparingand antifractureefficacyofsupplemen
bioavailable'P"iftakenwithmeals.(25,26)Also,because low talcalciumdemonstratedhere mayrivalthat demonstrated
calcium intake is a marker for several dietary deficien forsomeofthecurrently approvedprescription-onlyagents
cies,(27) and because calcium supplements may aggravate that are used in the treatment of established osteoporo
certainof them,(28) food sources of calcium are preferable SiS.(30,31) Thus, in osteoporosis treatment trials that com-
1966 RECKER ET AL.
pare "agent" to "control" when the control group has re Group on Vertebral Fractures 1995Assessingvertebral frac
ceivedcalciumsupplementation, thefailuretodemonstrate tures. J Bone Miner Res 10:518-523.
adifferenceisnot necessarilyto be taken as"noeffect"of 15. Chun YW, Jiao L, Jergas M, Genant HK 1995 Diagnosing
the treatment agent. incidentvertebralfractures: A comparison between quantita
tivemorphometryandastandardizedvisual(semiquantitative)
In summary,our studyshowedthat calciumsupplemen
approach. In:GenantHK,Jergas M,van KuijkC,eds. Verte
tation of a group of elderlywomen with lowselfselected
bral Fracture inOsteoporosis. Radiological Research & Edu
calciumintake not onlyreduces the riskof incident spine
cation Foundation,San Francisco, CA, U.S.A.,pp. 281-291.
fractures in those who already have them, but also halts
16. Kleinbaum DG, Kupper LL, Morgenstern H 1982Epidemio
measurable bone loss. logicResearch. Lifetime LearningPublications, Belmont, CA,
U.S.A.
17. Kahn HA, Sempos CT 1989Statistical MethodsinEpidemiol
ACKNOWLEDGMENTS ogy.Oxford University Press, NewYork, NY, U.S.A.
18. Anonymous 1988SAS/Stat User's Guide: Statistical Analysis
This work was supported by grants from the National Systems.SASInstituteInc.,Cary, NC,U.S.A.
19. RiggsBL,WahnerHW,Seeman E,etal1982Changesinbone
Dairy Promotion and Research Board, and the National
density of the proximal femur and spine with aging: Differ
Institutes of Health, AR-40832. The calcium supplement
ences between the postmenopausal and senile osteoporosis
wassupplied byLederle Laboratories.
syndromes. JClin Invest 70:716-723.
20. Anonymous 1989Recommended dietary allowance. National
ResearchCouncil.National Academy Press,Washington,DC,
REFERENCES U.S.A.,pp. 174-183.
21. Anonymous 1994 Optimal calcium intake: NIH Consensus
1. HeaneyRP 1993Nutritionalfactorsinosteoporosis.Annu Rev DevelopmentPanel. JAMA272:1942-1948.
Nutr 13:287-316. 22. Chevalley T, Rizzoli R, Nydegger V, et al. 1994 Effects of
2. NordinBEC,HeaneyRP 1990Calciumsupplementation ofthe calcium supplements on femoral bone mineral density and
diet: Justified bypresentevidence. BrMed J300:1056-1060. vertebral fracture rate in vitamin-D-replete elderly patients.
3. Barrett-ConnorE 1989The RDA for calcium in the elderly: OsteoporosisInt 4:245-252.
Too little, too late. CalcifTissue Int 44:303-307. 23. Matkovic V, Kostial K, Simonovic I, Buzina R, Brodarec A,
4. Arnaud CD, Sanchez SD 1990The role of calcium in osteo Nordin BEC1979Bonestatusandfractureratesintworegions
porosis.Annu Rev Nutr 10:397-414. ofYugoslavia.Am J ClinNutr32:540-549.
5. Marcus R 1987Calcium intake and skeletal integrity: Isthere 24. Heaney RP, Recker RR, Weaver CM 1990Absorbability of
acritical relationship?J Nutr 117:631-635. calciumsources:Thelimitedroleofsolubility.CalcifTissueInt
6. Chevalley T, Rizzoli R, Nydegger V, et al 1995 Effects of 46:300-304.
calcium supplements on femoral bone mineral density and 25. Recker RR 1985Calcium absorption and achlorhydria. New
vertebral fracture rate in vitamin D-replete elderly patients. Engl J Med 313:70-73.
OsteoporosisInt 4:245-252. 26. Heaney RP, Smith KT, Recker RR, Hinders SM 1989Meal
7. Reid IR,Ames RW, EvansMC,GambleGD, SharpeSJ1995 effectson calciumabsorption. AmJ ClinNutr 49:372-376.
Long-term effects of calcium supplementation on bone loss 27. Barger-Lux MJ, Heaney RP, Packard PT, Lappe JM, Recker
and fractures in postmenopausalwomen: a randomized con RR 1992 Nutritional correlates of low calcium intake. Clin
trolled trial. AmJ Med 98:331-335. Appl Nutr2:39-44.
8. ChapuyMC,Arlot ME,DuboeufF,etal1993Vitamin D and 28. Hallberg L, Brune M, Erlandsson MS, Rossander-Hulten L
3
calcium to prevent hip fractures in elderlywomen. NewEngl 1991Calcium: Effect of different amounts on nonherne- and
J Med327:1637-1642. heme-ironabsorptioninhumans. AmJClinNutr53:112-119.
9. MusgraveKO,Gimbalvo L,LeclercHL, Cook RA, Rosen CJ 29. Ross PD, Davis JW, Epstein RS, Wasnich RD 1991 Pre
1989Validationofaquantitativefoodfrequencyquestionnaire existing fractures and bone mass predict vertebral fracture
for rapid assessment of dietary calcium intake. J Am Diet incidence inwomen. Ann Int Med 114:919-923.
Assoc89:1484-1488. 30. Burckhardt P, Burnand B 1993The effect of treatment with
10. Melton U, Lane AW, Cooper C, Eastell R, O'Fallon WM, calcitonin onvertebralfracture rate inosteoporosis. Osteopo
RiggsBL1993Prevalence andincidenceofvertebraldeformi rosisInt 3:24-30.
ties. Osteoporosis Int3:113-119. 31. Villareal DT, Rupich RC, Pacifici R, et al 1992 Effect of
11. Davies KM, Recker RR, Heaney RP 1989Normal vertebral estrogenandcalcitoninonvertebralbonedensityandvertebral
dimensions and normal variation in serial measurements of height inosteoporoticwomen. OsteoporosisInt 2:70-73.
vertebrae.J Bone Miner Res 4:341-349.
12. Davies KM, Recker RR, Heaney RP 1993Revisable criteria Address reprint requests to:
forvertebraldeformity. OsteoporosisInt 3:265-270. Robert R.Recker, M.D.
13. Davies KM, Recker RR, Heaney RP 1995An expert-systems 601North 30th Street
approach to the detection ofvertebral deformity. In: Genant Omaha, NE 68131, U.SA.
HK, Jergas M, van Kuijk C (eds.) Vertebral Fractures in
Osteoporosis. Radiological Research & Education Founda
tion, San Francisco, CA, U.S.A.,pp. 261-270. Received in original form May 8, 1996;in revised form July 26,
14. Cummings SR, National Osteoporosis Foundation Working 1996;acceptedAugust 5,1996.
